HemosIL APTT-SP (Liquid) - Taiwan Registration 0cffc5f4fb5269656f459b178b0b3b43
Access comprehensive regulatory information for HemosIL APTT-SP (Liquid) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 0cffc5f4fb5269656f459b178b0b3b43 and manufactured by INSTRUMENTATION LABORATORY CO.. The authorized representative in Taiwan is Werfen Taiwan Limited.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
0cffc5f4fb5269656f459b178b0b3b43
Ministry of Health Medical Device Import No. 031421
DHA05603142100
Product Details
This product is used with the IL Coagulation System to measure activated partial thromboplastin time (APTT) in vitro on fresh citrate acidified fresh plasma as a general screening procedure to evaluate intrinsic coagulation pathways and monitor patients receiving heparin anticoagulant therapy.
B Hematology and pathology devices
B7925 Partial coagulation time test
Imported from abroad
Dates and Status
Aug 15, 2018
Aug 15, 2028